Taro Pharmaceutical Industries Ltd. logo
Taro Pharmaceutical Industries Ltd. TARO
$ 42.97 0.0%

Annual report 2022
added 07-25-2022

report update icon

Taro Pharmaceutical Industries Ltd. Financial Ratios 2011-2024 | TARO

Annual Financial Ratios Taro Pharmaceutical Industries Ltd.

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

23.3 -4.7 11.2 14.9 16.9 9.2 9.7 10.9 12.1 8.9 36.3 6.7

P/S

2.4 3.3 4.2 6.3 5.4 4.8 5.5 6.1 5.7 3.5 11.8 2.4

EPS

1.6 -10.1 6.3 7.2 5.3 11.1 12.6 11.3 8.1 6.0 - 4.1

EV (Enterprise Value)

1.57 B 1.94 B 2.45 B 3.85 B 3.23 B 3.84 B 4.91 B 5.1 B 4.4 B 2.34 B 1.72 B 1.31 B

EBITDA per Share

2.37 -10.2 6.97 8.07 7.96 12.8 14.7 12.7 10.1 7.75 1.59 5.02

EV/EBITDA

-4.7 8.0 11.5 9.4 6.8 7.4 8.8 9.3 6.2 21.3 5.0

PEG

-0.28 0.08 -1.19 0.4 -0.32 -0.74 0.83 0.28 0.33 0.02 -0.49 0.04

P/B

0.8 1.1 1.3 2.2 1.6 2.0 2.7 3.7 4.3 2.7 2.8 2.2

P/CF

-8.5 40.1 10.1 14.3 12.2 10.5 13.9 13.6 13.1 9.9 22.4 7.0

ROE %

3.40 -22.70 11.58 14.79 9.58 22.07 28.01 34.30 35.49 30.03 7.64 32.21

ROA %

2.68 -16.06 10.43 13.20 8.68 19.93 24.72 27.87 28.06 24.06 5.52 22.96

ROCE %

3.64 -23.80 11.60 15.44 13.66 24.76 31.63 36.96 41.73 35.95 10.07 33.81

Current Ratio

4.7 3.4 9.9 6.8 8.8 9.5 7.6 4.9 4.2 4.7 3.3 3.1

DSO

149.7 149.2 133.9 151.6 178.2 136.7 110.3 112.3 77.7 67.1 292.1 90.5

DIO

265.9 241.1 224.3 241.1 266.0 247.7 297.9 235.6 239.4 227.2 869.7 222.6

DPO

2.1 4.5 4.5 109.1 114.7 93.6 143.9 122.8 108.5 96.6 447.5 115.2

Operating Cycle

415.6 390.3 358.2 392.7 444.2 384.4 408.2 347.8 317.1 294.3 1161.7 313.1

Cash Conversion Cycle

413.4 385.8 353.8 283.6 329.5 290.8 264.3 225.1 208.6 197.7 714.2 197.9

All numbers in USD currency

Quarterly Financial Ratios Taro Pharmaceutical Industries Ltd.

2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 1.06 - - - 0.58

EBITDA per Share

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 1.59 - - - 0.86

ROE %

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 7.63 15.27 15.27 7.63 7.63 - - - -

ROA %

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 5.52 11.03 11.03 5.52 5.52 - - - -

ROCE %

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 10.13 20.26 20.26 10.13 10.13 - - - -

Current Ratio

- - - - - - - 3.4 - - - 10.1 - - - 9.5 - - - 10.9 - - - 10.6 - - - 8.7 - - - 5.4 - - - 4.9 - - - 5.1 - - - 3.7 3.5 - - -

DSO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 72.9 - - - -

DIO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 215.4 - - - -

DPO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 23.6 - - - -

Operating Cycle

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 288.3 - - - -

Cash Conversion Cycle

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 264.7 - - - -

All numbers in USD currency